Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses
Authors:
- Amr AminAAAmr Amin
- Alaaeldin A. HamzaAHAlaaeldin A. Hamza
- Sayel DaoudSDSayel Daoud
- Kamal KhazanehdariKKKamal Khazanehdari
- Ala'A Al HroutAHAla'A Al Hrout
- Badriya BaigBBBadriya Baig
- Amphun ChaiboonchoeACAmphun Chaiboonchoe
- Thomas E. AdrianTAThomas E. Adrian
- Nazar ZakiNZNazar Zaki
- Kourosh Salehi-AshtianiKSKourosh Salehi-Ashtiani
- 11 February 2016
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Recent Patents on Anti-Cancer Drug Discovery
- Vol. 11 (1) , 121-133
Abstract
Background: The angiogenesis inhibitor, sorafenib, remains the only available therapy of hepatocellular carcinoma (HCC). Only recently patents of VEGF receptors-3 inhibitors are developed. Thus, a novel approach against HCC is essential for a better therapeutic outcome. Objective: The aims of this study were to examine the chemopreventive action of saffron’s main biomolecule, crocin, against chemically-induced liver cancer in rats, and to explore the mechanisms by which crocin employs its anti-tumor effects. Method: We investigated the anti-cancer effect of crocin on an experimental carcinogenesis model of liver cancer by studying the anti-oxidant, anti-inflammatory, anti-proliferation, pro-apoptotic activities of crocin in vivo. In addition, we provided a network analysis of differentially expressed genes in tissues of animals pre-treated with crocin in comparison to induced-HCC animals’ tissues. To further support our results, in vitro analysis was carried out. We assessed the effects of crocin on HepG2 cells viability by treating them with various concentrations of crocin; in addition, effects of crocin on cell cycle distribution of HepG2 cells were investigated. Results: Findings reported herein demonstrated the anti-proliferative and pro-apoptotic properties of crocin when administrated in induced-HCC model. Crocin exhibited anti-inflammatory properties where NF-kB, among other inflammatory markers, was inhibited. In vitro analysis confirmed crocin’s effect in HepG2 by arresting the cell cycle at S and G2/M phases, inducing apoptosis and down regulating inflammation. Network analysis identified NF-kB as a potential regulatory hub, and therefore, a candidate therapeutic drug target. Conclusion: Taken together, our findings introduce crocin as a candidate chemopreventive agent against HCC.Keywords
This publication has 46 references indexed in Scilit:
- Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular dockingEuropean Journal of Medicinal Chemistry, 2015
- Thiazole: A promising heterocycle for the development of potent CNS active agentsEuropean Journal of Medicinal Chemistry, 2015
- Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cellsBiomedicine & Pharmacotherapy, 2013
- Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinomaHepatology, 2011
- Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological studyActa Histochemica, 2010
- Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty ConnectionHepatology, 2010
- HDAC inhibitors in models of inflammation-related tumorigenesisCancer Letters, 2009
- HDAC expression and clinical prognosis in human malignanciesCancer Letters, 2009
- Regulation of glutathione transferase P: A tumor marker of hepatocarcinogenesisBiochemical and Biophysical Research Communications, 2007
- HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBαBiochemical Pharmacology, 2005